205 related articles for article (PubMed ID: 16709312)
1. Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients.
Howles CM; Saunders H; Alam V; Engrand P;
Curr Med Res Opin; 2006 May; 22(5):907-18. PubMed ID: 16709312
[TBL] [Abstract][Full Text] [Related]
2. An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.
Vlaisavljević V; Meden-Vrtovec H; Lewandowski P; Radwan M; Langerova A; Vicena M; Války J; Herman M; Usoniene A; Treijs G
Curr Med Res Opin; 2010 Apr; 26(4):819-25. PubMed ID: 20121657
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
Tarlatzis B; Tavmergen E; Szamatowicz M; Barash A; Amit A; Levitas E; Shoham Z
Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
[TBL] [Abstract][Full Text] [Related]
4. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
Howles CM; Alam V; Tredway D; Homburg R; Warne DW
Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
6. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
Porter R; Kissel C; Saunders H; Keck C
Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
9. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
[TBL] [Abstract][Full Text] [Related]
10. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.
Corifollitropin Alfa Dose-finding Study Group
Hum Reprod; 2008 Nov; 23(11):2484-92. PubMed ID: 18684735
[TBL] [Abstract][Full Text] [Related]
11. FSH: urinary and recombinant.
Palagiano A; Nesti E; Pace L
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S30-3. PubMed ID: 15196713
[TBL] [Abstract][Full Text] [Related]
12. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
13. Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).
Fatemi H; Bilger W; Denis D; Griesinger G; La Marca A; Longobardi S; Mahony M; Yin X; D'Hooghe T
Reprod Biol Endocrinol; 2021 May; 19(1):68. PubMed ID: 33975610
[TBL] [Abstract][Full Text] [Related]
14. Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility.
Loutradis D; Drakakis P; Vlismas A; Antsaklis A
Curr Opin Investig Drugs; 2009 Apr; 10(4):372-80. PubMed ID: 19337959
[TBL] [Abstract][Full Text] [Related]
15. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study.
Hugues JN; Cédrin-Durnerin I; Howles CM; ; Amram M; Angelini A; Balen A; Barbereau D; Birkhauser M; Boujenah A; De Leo V; De Placido G; Dessole S; Favrin S; Ferrazi E; Gay C; Germond M; Hedon B; Hocke C; Jolly C; Lamarca-Roth E; Lanzone A; Marchand F; Marcolin G; Mascaretti G; Moreau L; Massobrio M; Nappi C; Pardi G; Pennehouat G; Porcu E; Seibert M; Selvaggi L; Thiers D; Venturini P
Hum Reprod; 2006 Nov; 21(11):2817-22. PubMed ID: 16877376
[TBL] [Abstract][Full Text] [Related]
16. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women.
Kaufmann R; Dunn R; Vaughn T; Hughes G; O'Brien F; Hemsey G; Thomson B; O'Dea LS
Clin Endocrinol (Oxf); 2007 Oct; 67(4):563-9. PubMed ID: 17692110
[TBL] [Abstract][Full Text] [Related]
18. Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jan; 14():1. PubMed ID: 26733057
[TBL] [Abstract][Full Text] [Related]
19. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
Demirol A; Gurgan T
Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
